Tilray to import CBD for US clinical trials on alcohol abuse and post-traumatic stress disorders

  • 📰 CNBC
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 72%

Education Education Headlines News

Education Education Latest News,Education Education Headlines

Tilray to supply CBD for clinical trials on alcohol use and post-traumatic stress disorders

's CBD-derived drug, Epidiolex. Marmar thinks CBD, if proven to be effective, could treat a broad range of psychological conditions, similar to how antibiotics treat all kinds of bacterial infections.

The trials will test whether CBD is safe and effective. NYU will start recruiting patients this summer — 40 for the eight-week alcohol study and 48 for the other study, which will take six weeks and probe alcohol use and PTSD. This is Tilray's second partnership with a U.S. academic institution to study cannabis. Tilray announced in the fall it will work with the University of California, San Diego to study whether cannabis can treat essential tremor, a neurological disorder that causes involuntary shaking.

"Ultimately, there's so much interest in CBD as a treatment modality, but there's simply not a lot of clinical research," he said, adding that Tilray wants to continue partnering with major research institutions like NYU to fill those knowledge gaps.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

BrendanTKennedy Interesting

Alcohol use disorder is just a fancy term for alcoholism. But, I'm glad to see that medical science is exploring this as a treatment option; CBD is good for treating a wide range of maladies.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in EDUCATİON

Education Education Latest News, Education Education Headlines